Pennsylvanias Medicaid spending for GLP-1s like Ozempic, Wegovy, and Zepbound exploded to an estimated $1.3 billion last year from $233 million in 2022, the year before Medicaid started covering the drugs for obesity
Special help for meno belly Hormonal imbalances that develop during perimenopause and menopause can make it harder to lose and easier to gain
Marxer, M., Vollenweider, V., and Schmid-Hempel, P., Phil
Genomic and surface proteomic analysis of the canine pathogen staphylococcus pseudintermedius reveals proteins that mediate adherence to the extracellular matrix
Flushing, headache, nausea, and local irritation are the leading complaints and usually resolve when infusion speed is reduced
Does not interfere with insulin sensitivity, making it potentially safer for individuals at risk of diabetes or metabolic disorders